FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of pharmaceutics and medicine and deals with pharmaceutical composition for treatment of chronic heart failure, which includes as affective ingredient 5-[2-propyloxy-5-(1-methyl-2-pyrrolidinyl-ethyl-amidosulfonyl)phenyl]-1-methyl-3propyl-1,6-dihydro-7H-pyrazolo(4,3-d)pyrimidin-7-one, method of chronic heart failure treatment and application of said compound for obtaining pharmaceutical form for treatment of chronic heart failure.
EFFECT: invention ensures relief of chronic heart failure symptoms, prevention of left ventricle dilatation, reduction of ventricular wall thinning, control of ventricular fibrosis and reduction of side effects.
5 cl, 1 tbl, 3 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PYRAZOLPYRAMIDINON DERIVATIVE-CONTAINING MEDICINE FOR LIVER DISEASES TREATMENT AND PREVENTION | 2005 |
|
RU2369392C2 |
MEDICATION FOR TREATMENT AND PREVENTION OF PROSTATIC HYPERPLASIA, CONTAINING PYRAZOLOPYRIMIDINONE DERIVATIVE | 2006 |
|
RU2418590C2 |
DERIVATIVES OF PYRAZOLOPYRIMIDINONE FOR IMPOTENCY TREATMENT AND METHOD FOR THEIR PREPARING | 1999 |
|
RU2220145C2 |
METHOD FOR TREATING PATIENTS WITH CHRONIC HEART FAILURE AT THE BACKGROUND OF ISCHEMIC CARDIAC DISEASE | 2000 |
|
RU2213559C2 |
METHOD FOR SELECTING CHRONIC CARDIAC INSUFFICIENCY PATIENTS TREATABLE WITH NEBIVOLOL | 2006 |
|
RU2305498C1 |
PDE INHIBITORS AND THEIR COMBINATIONS FOR TREATMENT OF UROLOGIC DISORDERS | 2006 |
|
RU2435588C2 |
METHOD FOR PREPARING DERIVATIVES OF PYRAZOLOPYRIMIDINONE FOR TREATMENT OF IMPOTENCY | 2001 |
|
RU2236410C2 |
METHOD FOR PREDICTING THE DEVELOPMENT OF LIFE-THREATENING VENTRICULAR ARRHYTHMIAS AND SUDDEN CARDIAC DEATH IN PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILURE WITH A REDUCED EJECTION FRACTION WITHIN 12 MONTHS AFTER IMPLANTATION OF A CARDIOVERTER DEFIBRILLATOR | 2021 |
|
RU2758120C1 |
METHOD FOR REHABILITATION OF ELDERLY PATIENTS WITH ISCHEMIC HEART DISEASES ACCOMPANIED BY CHRONIC HEART INSUFFICIENCY FOLLOWING MYOCARDIAL INFARCTION | 2014 |
|
RU2554756C1 |
4-FLUORO-N-INDANE-2-YLBENZAMIDE AND ITS USING AS PHARMACEUTICAL AGENT | 2002 |
|
RU2308946C2 |
Authors
Dates
2011-06-10—Published
2008-06-03—Filed